Featured Research

from universities, journals, and other organizations

First Human Trial Of Bioartificial Kidney Shows Promise For Acute Renal Failure

Date:
November 9, 2004
Source:
University Of Michigan Health System
Summary:
The first test in humans of a bioartificial kidney offers hope of the device's potential to save the lives of people with acute renal failure, researchers at the University of Michigan Health System report.

ANN ARBOR, MI - The first test in humans of a bioartificial kidney offers hope of the device's potential to save the lives of people with acute renal failure, researchers at the University of Michigan Health System report.

Related Articles


While the phase I/II study was designed primarily to look at the safety of using this device on humans, the results also suggest improvement in kidney function. The patients enrolled in the trial faced an average 86 percent likelihood of dying at the hospital. Six of those 10 patients survived more than 30 days after treatment with the bioartificial kidney. The study appears in the October issue of the journal Kidney International.

“These results showed this type of human adult stem progenitor/stem cell is well-tolerated by patients with acute renal failure, and there were some very compelling and resulted in some improvement outcomes of the patients' clinical conditions. It's a small study but it was compelling enough for us and the FDA to agree to go forward with a full phase II study,” says lead study author H. David Humes, M.D., professor of Internal Medicine at the U-M Medical School. Humes developed the renal tubule assist device, or RAD, the cell cartridge that is key to the bioartificial kidney.

The RAD is being developed for future commercial applications under license to Nephros Therapeutics Inc.

The phase I/II study enrolled 10 patients at UMHS and the Cleveland Clinic Foundation. Patients were seriously ill, with acute renal failure and multiple other illnesses, including sepsis, multiple organ failure, acute respiratory distress syndrome and postoperative complications.

Each patient received up to 24 hours of treatment with the renal tubule assist device. Several patients were taken off the treatment earlier because of reactions such as hypoglycemia or low platelet counts, or because of complications related to their other medical conditions.

The bioartificial kidney includes a cartridge that filters the blood as in traditional kidney dialysis. That cartridge is connected to a renal tubule assist device, which is made of hollow fibers lined with a type of kidney cell called renal proximal tubule cells. These cells are intended to reclaim vital electrolytes, salt, glucose and water, as well as control production of immune system molecules called cytokines, which the body needs to fight infection.

Conventional kidney dialysis machines remove these important components of blood plasma, along with toxic waste products, and cannot provide the cytokine regulation function of living cells. Traditional therapy for patients with acute or chronic renal failure involves dialysis or kidney transplant, both of which have limitations.

Humes and his colleagues began developing this technology a decade ago, identifying the adult progenitor/stem cells and testing the device in animals. Initial testing in animals, published in the journal Nature Biotechnology in April 1999, found the cells in the RAD perform the metabolic and hormonal functions lost in acute renal failure.

Eventually, researchers hope the device can become implantable in patients with acute or chronic renal failure as a long-term replacement for kidney function. More testing is needed before that can become a reality, and any standard use of this therapy is still many years off.

“The long-term goal, if this shows effectiveness in patients with end stage renal disease, is to build a fully implantable device. Our lab is working with engineers at U-M and the Cleveland Clinic to make nanofabricated membranes that can miniaturize the device so it can be implanted and fully replace organ function,” Humes says.

For now, a randomized, controlled phase II trial of the RAD in acute renal failure is currently underway at six academic medical centers under investigational new drug, sponsored by Nephros Therapeutics Inc. The study is expected to expand to additional centers later this year. UMHS researchers also have planned, for late 2005, a phase I/II trial to investigate the safety of the RAD for people with end-stage chronic renal failure. Investigators are not looking for volunteers for that trial, and the device is not ready to be implanted in patients.

In addition to Humes, U-M study authors were William Weitzel, M.D., assistant professor of Nephrology; Robert Bartlett, M.D., professor of Surgery; and Fresca Swaniker, M.D., assistant professor of Surgery. Other authors were Emil Paganini, M.D., of the Cleveland Clinic, and Jack Luderer , M.D., and Joseph Sobota , M.D., of Nephros Therapeutics .

Funding for the study was from the National Institutes of Health, the Michigan Life Sciences Corridor Fund and Nephros Therapeutics. The renal assist device technology is owned by the University of Michigan and licensed to Nephros Therapeutics Inc., a biotechnology spin-off company of U-M. Humes, Luderer and Sobota are shareholders in Nephros.

Patients seeking more information about the renal assist device can call (800) 742-2300, category 6500.

Reference: Kidney International, Vol. 66, No. 4, pp. 1578-1588.


Story Source:

The above story is based on materials provided by University Of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan Health System. "First Human Trial Of Bioartificial Kidney Shows Promise For Acute Renal Failure." ScienceDaily. ScienceDaily, 9 November 2004. <www.sciencedaily.com/releases/2004/11/041103235146.htm>.
University Of Michigan Health System. (2004, November 9). First Human Trial Of Bioartificial Kidney Shows Promise For Acute Renal Failure. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2004/11/041103235146.htm
University Of Michigan Health System. "First Human Trial Of Bioartificial Kidney Shows Promise For Acute Renal Failure." ScienceDaily. www.sciencedaily.com/releases/2004/11/041103235146.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins